0000899243-20-012297.txt : 20200507 0000899243-20-012297.hdr.sgml : 20200507 20200507191243 ACCESSION NUMBER: 0000899243-20-012297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200505 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOLMLUND JON T CENTRAL INDEX KEY: 0001227367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 20858201 BUSINESS ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-05 0 0001563577 Galera Therapeutics, Inc. GRTX 0001227367 HOLMLUND JON T C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 0 1 0 0 Chief Medical Officer Common Stock 2020-05-05 4 M 0 3064 1.07 A 3064 D Common Stock 2020-05-05 4 S 0 3064 12.16 D 0 D Common Stock 2020-05-06 4 M 0 1489 1.07 A 1489 D Common Stock 2020-05-06 4 S 0 1489 12.00 D 0 D Common Stock 2020-05-07 4 M 0 2059 1.07 A 2059 D Common Stock 2020-05-07 4 S 0 2059 12.0007 D 0 D Stock Option 1.07 2020-05-05 4 M 0 3064 0.00 D 2023-01-22 Common Stock 3064 17345 D Stock Option 1.07 2020-05-06 4 M 0 1489 0.00 D 2023-01-22 Common Stock 1489 15856 D Stock Option 1.07 2020-05-07 4 M 0 2059 0.00 D 2023-01-22 Common Stock 2059 13797 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option has fully vested and is currently exercisable. /s/ Christopher Degnan, Attorney-in-Fact for Jon T. Holmlund 2020-05-07